EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Huntington's disease clinical trials update: March 2025

Mena Farag iD, Sarah J Tabrizi, Edward J Wild

Journal of Huntington's Disease · 2025-05 · 14 (2) · 191-206

DOI: 10.1177/18796397251337000 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Huntington's Disease, online erschienen am 30.04.2025. Verfasst von Mena Farag und 2 weiteren Autor:innen. Beteiligte Einrichtung: Huntington's Disease Centre, UCL Queen Square Institute of Neurology, London, UK. Hauptthemen laut MEDLINE: Huntington Disease, Clinical Trials as Topic. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this edition of the Huntington's Disease Clinical Trials Update, we expand on the ongoing phase I clinical trial of ALN-HTT02 from Alynlam Pharmaceuticals. We also report on the SAGE-718 (also known as dalzanemdor) program from Sage Therapeutics, with results of the phase II DIMENSION study and the recent termination of the open-label phase III PURVIEW study. Additionally, we discuss recent developments in the regulatory pathway for AMT-130, following discussions between uniQure and the U.S. Food and Drug Administration regarding key aspects of accelerated approval. Finally, we provide a comprehensive listing of all currently registered and ongoing clinical trials in Huntington's disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington DiseaseClinical Trials as TopicHumansDrug Approval

Stichwörter der Autor:innen

Huntington's diseaseclinical trials

Autor:innen und Institutionen

  • Huntington's Disease Centre, UCL Queen Square Institute of Neurology, London, UK.

ORCID-Profile: Mena Farag

Förderung

  • Wellcome Trust

Zitieren

APA

Farag, M., Tabrizi, S. J., & Wild, E. J. (2025). Huntington's disease clinical trials update: March 2025. Journal of Huntington's Disease, 14(2), 191-206. https://doi.org/10.1177/18796397251337000

Vancouver

Farag M, Tabrizi SJ, Wild EJ. Huntington's disease clinical trials update: March 2025. Journal of Huntington's Disease. 2025;14(2):191-206. doi:10.1177/18796397251337000

BibTeX
@article{Farag2025,
  author = {Farag, Mena and Tabrizi, Sarah J and Wild, Edward J},
  title = {Huntington's disease clinical trials update: March 2025},
  journal = {Journal of Huntington's Disease},
  year = {2025},
  volume = {14},
  number = {2},
  pages = {191--206},
  doi = {10.1177/18796397251337000}
}
Kostenlos starten →